NEW ORLEANS — Advancements in laser technology have opened the door to new treatment options for acne patients, according to a presenter at the American Academy of Dermatology Annual Meeting.Prior to recent years, lasers were not an integral part of acne treatment due to a lack of efficiency, according to Emmy M. Graber, MD, MBA, FAAD, president and founder of The Dermatology Institute of
NEW ORLEANS — A greater proportion of patients with molluscum contagiosum experienced complete clearance rates with berdazimer gel 10.3% vs. vehicle, according to a study presented at the American Academy of Dermatology Annual Meeting.“Clinicians can know that a novel medication has been developed that is safe and effective in treating molluscum contagiosum,” John C. Browning,
NEW ORLEANS — A novel monoclonal antibody could be a promising treatment for hidradenitis suppurativa as phase 2 clinical trial results showed an improvement in total abscess and nodule count after 16 weeks of treatment.
Eltrekibart (LY3041658, Eli Lilly) is a humanized monoclonal antibody that binds to the seven ligands that signal through CXCR1 and CXCR2, according to Seth Forman, MD,
NEW ORLEANS — Symptoms of prurigo nodularis were significantly improved after 16 weeks of monotherapy with nemolizumab, according to a presenter at the American Academy of Dermatology Annual Meeting.“Prurigo nodularis, PN, is characterized by these intensely itchy nodules that are commonly on the extremities and the trunk,” Shawn G. Kwatra, MD, associate professor of dermatology
NEW ORLEANS — Phase 3 trial results found delgocitinib cream to significantly improve patient and clinician-reported outcomes of hand eczema, according to a presenter at the American Academy of Dermatology Annual Meeting.“Chronic hand eczema is one of the most frequent and chronic inflammatory disorders affecting hands,” Robert Bissonnette, MD, MSc, CEO and medical director of